$64.22
1.59%
Nasdaq, Oct 10, 10:00 pm CET
ISIN
US40131M1099
Symbol
GH

Guardant Health, Inc. Stock price

$64.22
+7.65 13.52% 1M
+23.08 56.10% 6M
+33.67 110.21% YTD
+43.61 211.60% 1Y
+12.48 24.12% 3Y
-44.73 41.06% 5Y
+32.02 99.44% 10Y
+32.02 99.44% 20Y
Nasdaq, Closing price Fri, Oct 10 2025
-1.04 1.59%

Key metrics

Basic
Market capitalization
$8.0b
Enterprise Value
$8.5b
Net debt
$486.4m
Cash
$629.1m
Shares outstanding
124.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
9.7 | 8.4
EV/Sales
10.3 | 9.0
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-9.4%
Return on Equity
312.5%
ROCE
-42.1%
ROIC
-76.5%
Debt/Equity
-3.7
Financials (TTM | estimate)
Revenue
$828.9m | $948.0m
EBITDA
$-419.1m | $-226.7m
EBIT
$-460.7m | $-389.1m
Net Income
$-413.8m | $-394.8m
Free Cash Flow
$-272.0m
Growth (TTM | estimate)
Revenue
28.8% | 28.3%
EBITDA
12.0% | 43.5%
EBIT
11.2% | 12.3%
Net Income
15.7% | 9.5%
Free Cash Flow
9.0%
Margin (TTM | estimate)
Gross
62.8%
EBITDA
-50.6% | -23.9%
EBIT
-55.6%
Net
-49.9% | -41.6%
Free Cash Flow
-32.8%
More
EPS
$-3.4
FCF per Share
$-2.2
Short interest
7.0%
Employees
2k
Rev per Employee
$370.0k
Show more

Is Guardant Health, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,999 stocks worldwide.

Guardant Health, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

34 Analysts have issued a Guardant Health, Inc. forecast:

31x Buy
91%
2x Hold
6%
1x Sell
3%

Analyst Opinions

34 Analysts have issued a Guardant Health, Inc. forecast:

Buy
91%
Hold
6%
Sell
3%

Financial data from Guardant Health, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
829 829
29% 29%
100%
- Direct Costs 308 308
20% 20%
37%
521 521
35% 35%
63%
- Selling and Administrative Expenses 625 625
35% 35%
75%
- Research and Development Expense 357 357
2% 2%
43%
-419 -419
12% 12%
-51%
- Depreciation and Amortization 42 42
3% 3%
5%
EBIT (Operating Income) EBIT -461 -461
11% 11%
-56%
Net Profit -414 -414
16% 16%
-50%

In millions USD.

Don't miss a Thing! We will send you all news about Guardant Health, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Guardant Health, Inc. Stock News

Neutral
Business Wire
3 days ago
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the third quarter 2025 after market close on Wednesday, October 29, 2025. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be ...
Neutral
Business Wire
13 days ago
PALO ALTO, Calif.--(BUSINESS WIRE)---- $GH--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved its Guardant360® CDx as a companion diagnostic to identify advanced breast cancer patients with ESR1 mutations who may benefit from Eli Lilly and Company's Inluriyo (imlunestrant). Guardant360 CDx was ...
Neutral
Seeking Alpha
18 days ago
Guardant Health, Inc. (NASDAQ:GH ) Analyst/Investor Day September 24, 2025 9:00 AM EDT Company Participants Zarak Khurshid - Vice President of Investor Relations Helmy Eltoukhy - Co-Founder, Co-CEO & Chairman AmirAli Talasaz - Co-CEO & Director Darya Chudova - Chief Technology Officer Craig Eagle - Chief Medical Officer Christopher Freeman - Chief Commercial Officer of Oncology Jaime Boyle - Se...
More Guardant Health, Inc. News

Company Profile

Guardant Health, Inc. is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Redwood City, CA.

Head office United States
CEO Helmy Eltoukhy
Employees 2,010
Founded 2012
Website guardanthealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today